PRA023：PRA023 for Systemic Sclerosis with Interstitial Lung Disease

PRA023 for Systemic Sclerosis with Interstitial Lung Disease

ResearchersarestudyinganewmedicationcalledPRA023thathasanti-inflammatoryandantifibroticpropertiestodeterminehowwellitworksagainstsystemic ...。其他文章還包含有：「《併購》驚豔!!Prometheus結腸炎候選新藥PRA023緩解高達...」、「OP40PRA023DemonstratedEfficacyandFavorable...」、「MerckStrengthensImmunologyPipelinewithAcquisitionof...」、「Phase2ARTEMIS」、「DOP87TheAnti」、「DOP87TheAnti」、「Tuliso...

查看更多離開網站

prometheus biosciences PRA023

Provide From Google

《併購》驚豔!! Prometheus結腸炎候選新藥PRA023緩解高達 ...

http://www.genetinfo.com

PRA023 是一種針對腫瘤壞死因子(TNF) 樣配體1A (TL1A) 的人源化單克隆抗體。PRA023 以高親和力和特異性結合可溶性和膜相關的人TL1A，用於治療免疫疾病， ...

Provide From Google

OP40 PRA023 Demonstrated Efficacy and Favorable ...

https://www.ecco-ibd.eu

PRA023 was effective with favorable tolerability for the induction of clinical remission and endoscopic improvement in moderately to severely active UC. A Phase ...

Provide From Google

Merck Strengthens Immunology Pipeline with Acquisition of ...

https://www.merck.com

PRA023 is a humanized monoclonal antibody directed to tumor necrosis factor (TNF)-like ligand 1A (TL1A). PRA023 binds both soluble and membrane ...

Provide From Google

Phase 2 ARTEMIS

https://academic.oup.com

PRA023 is an anti-TL1A monoclonal antibody in development for multiple inflammatory/fibrotic diseases using a precision medicine approach with a ...

Provide From Google

DOP87 The Anti

https://www.ecco-ibd.eu

Tumor necrosis factor-like cytokine 1A (TL1A) is an upstream regulator of pro-inflammatory cytokines and fibrosis signals. PRA023 is an anti-TL1A monoclonal ...

Provide From Google